Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2F&esheet=53901571&newsitemid=20240226565897&lan=en-US&anchor=Takeda&index=1&md5=66a3b376ad586d49f3651a4e8ba4fded) (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=53901571&newsitemid=20240226565897&lan=en-US&anchor=TSE%3A4502%2FNYSE%3ATAK&index=2&md5=330e6eb112da70d6ea46def0e3643fe6)) and Biological E. Limited (BE), a leading India-ba…